Pacira Pharmaceuticals

FDA approves non-opioid drug for shoulder surgeryFDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.
Alternatives to Opioids
Alternatives to OpioidsHow Trinity Health and Pacira are minimizing opioid use.
Pacira makes nice with FDA; encouraging for ExparelAmicable resolution between FDA and Pacira Pharmaceuticals, Inc., which reaffirms the broad indication for Exparel (bupivacaine liposome injectable suspension).